港股異動丨綠城服務(02869.HK)跌4.38% 擬折價約7.12%配售2.666億股新股份
格隆匯6月3日丨綠城服務(02869.HK)跌4.38%,報10.48港元,總市值309億港元。公司今日與配售代理訂立配售協議,據此,配售代理(作為公司代理人)已同意(按個別但非共同或共同及個別基準)作為公司的配售代理行事,以根據配售協議所載條款及條件促使承配人按每股10.18港元的配售價認購(或若未能,則自身認購)2.666億股配售股份。配售價每股10.18港元較6月2日收市價10.96港元折讓約7.12%。假設配售股份根據配售事項悉數發行,公司自配售事項將獲得的所得款項總額及淨額估計分別為約27.14億港元及26.93億港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.